Curaleaf Earnings + Call Notes
Global cannabis leader reports Q124 results.
$339M Revs; est. $339.6M
$77M AEBITDA; est. $79.4M
$161M GP; est. $164.4M
$12.7M OI; est. $24.9M
48% GM; est. 48.4%
($51 M) NI; est. ($44M)
($.07 ) EPS; est. ($0.06)
“At this important inflection point in our industry and our Company, on the heels of rescheduling news, our expanded custody solutions and the advances in Europe, Curaleaf has evolved from an MSO to an MCO, a multi-country operator, a term which represents our global vision and business that today spans over 15 countries across the world.” Curaleaf Executive Chairman Boris Jordan
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.